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Background: Food challenge tests are the gold standard in diagnosing food allergy. Guidelines provide scoring
systems to classify symptoms during challenge and typically recommend that challenges are considered positive
when objective symptoms occur. However, currently no standard criteria for the definition of a positive challenge
outcome exists and interpretation of food challenges mainly depends on clinical judgment. This study aims to
assess inter- and intra-observer variability in outcomes of routinely performed peanut challenges in children.
Methods: All complete food challenge score sheets of double blind placebo controlled peanut challenges
performed in 2008-2010 in an academic hospital were included. Score sheets were reassessed independently by
three clinical experts including double reassessment in a subset of score sheets. Inter- and intra-observer variability
was evaluated using kappa statistics.
Results: We included 191 food challenge score sheets. Inter-observer agreement on overall challenge outcome was
moderate (κ = 0.59-0.65) and was fair (κ = 0.31-0.46) on challenges with symptoms. Intra-observer agreement on
overall challenge outcome was good (κ = 0.63-0.77) but was moderate (κ = 0.50-0.60) on challenges with symptoms.
Subjective symptoms (oral symptoms, abdominal complaints, food aversion) were significantly associated with
disagreement between observers.
Conclusions: We demonstrate that, despite strict adherence to guidelines, there is a considerable amount of
variability in reassessment of symptoms recorded on food challenges sheets between and within well trained
clinicians, especially when subjective symptoms occur.
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Food challenge tests are the gold standard in diagnosing
food allergy [1]. Several guidelines and symptom score
sheets exist to classify symptoms during challenge. A
food challenge is usually considered positive when clear
objective symptoms occur on verum and not on placebo
[1-3]. Whenever possible, symptoms are supported and ob-
jectified by measuring clinical parameters such as blood
pressure, oxygen saturation and lung function tests. How-
ever, no standard criteria for the definition of a positive
challenge outcome exist and the interpretation of food
challenges mainly depends on clinical judgment. Especially
when clear objective symptoms are absent, determination* Correspondence: f.c.vanerp@umcutrecht.nl
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unless otherwise stated.of food challenge outcome can be difficult. Clinicians may
then take other factors (course and reproducibility of
symptoms over time, patient characteristics, a “gut feeling”
or lessons learned from previous cases) into account to
determine challenge outcome. These factors come along
with clinical judgment in general and are not easily stan-
dardized nor implemented in guidelines. Until now no data
on the diagnostic accuracy of the interpretation of symp-
toms during food challenge are available. In this study we
describe inter- and intra-observer variability in reassess-
ment of the outcome of previous performed standardized
food challenges by measuring the agreement on the
outcome of food challenge score sheets.Methods
All complete Double Blind Placebo Controlled Food
Challenges (DBPCFCs) (n = 191) for peanut performedl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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for this study. Data were obtained as part of regular
patient care and collected retrospectively from elec-
tronic patient records in 2012. Food challenge score
sheets were used in strictly anonymous form, accord-
ing to the code of conduct for medical research ap-
proved by the hospital’s Medical Ethical Committee.
The DBPCFC protocol used in this study was described
earlier by Flinterman et al. [4] In short, increasing
amounts of defatted peanut flour from 0.01 to 3000 mg,
were given with time-intervals of 15-30 minutes with ran-
domly dispersed placebo’s. Challenges were performed by
a nurse practitioner specialized in food allergy and inter-
preted under supervision of an allergologist. When symp-
toms occurred the patient was fully examined and in case
of doubt or severe symptoms the allergologist was called
to interpret these symptoms. All signs and symptoms ob-
served during DBPCFC were recorded in detail on paper
food challenge score sheets including timing and adminis-
tration of doses by a trained nurse and any abnormalities
in vital signs (Table 1). Challenges were discontinued and
considered positive in case of persistent objective symp-
toms or if suggestive subjective symptoms (Oral allergy
symptoms (OAS)) occurred at 3 subsequent doses or a
severe subjective symptom (abdominal pain/nausea with
discomfort) lasted for more than 45 minutes. SymptomsTable 1 Example Food challenge score sheet
Minutes
after start
Portion Time (hr) Observations/Symptoms
Part 1
T= 0 1 10.30 At 10:35 patient reports mild
abdominal pain, the pain
disappeared spontaneously
within 10 minutes.
T=15 2 10.45 -
T=30 3 11.00 Patient does not like the food
and eats very slowly.
T=45 4 11.15 -
T=60 5 11.30 -
T=75 6 11.45 -
T=90 7 12.00 At 12:05 mild sneezing (2 times),
no other symptoms.
T=105 8 12.15 -
Part 2
T=120 9 12.30 -
T=150 10 13.00 At 13.15 Severe vomiting (1 time).
No other symptoms.
T=180 11 NA -
T=210 12 NA -
T =240 13 NA -
Other comments: Patient is a very difficult eater, and did not like the
food during challenge.within 15 minutes after a placebo dose were considered as
placebo reactions. The three observers were clinical ex-
perts in food allergy, regularly interpreted food challenges
according to the most recent clinical guidelines [2], had
the same criteria for classifying a challenge was positive
and worked in close cooperation with each other within
an expert centre of food allergy. Observer 1 (a paediatric
allergologist) performed food challenges in children
for 10 years and supervised included food challenges
(2-4 years ago). Observer 2 (a paediatric allergologist
in training) performed challenges for more than 5 years.
Observer 3 (dermatologist and immunologist) performed
food challenges in adults for more than 10 years. An-
onymous food challenges score sheets (blinded for patient
characteristics, randomization and challenge outcome)
were individually administrated to the observers. The ob-
servers received 25% duplicated score sheets randomly
dispersed with the other score sheets without their know-
ledge. They were asked to determine and argue DBPCFC
outcome as positive, negative or when information was in-
sufficient or doubtful as inconclusive. Agreement between
observers was defined as a concordant classification of all
three observers. Disagreement was defined as a discordant
classification between two or three observers.
Statistics
The kappa statistic (κ) was used to determine intra-
observer and inter-observer variability between different
pairs of observers on overall challenge outcomes and on
individual symptoms in challenges with symptoms re-
spectively. Interpretation of the Kappa value: <0.20 =
poor agreement; 0.21-0.40 = fair agreement; 0.41-0.60 =
moderate agreement; 0.61-0.80 = good agreement; 0.81-
1.0 = excellent agreement [5]. For univariable analyses of
the association between type of symptoms and the
agreement between observers, the chi-square statistic
or univariable logistic regression analysis was used. A
p-value <0.05 was considered statistically significant.
Results
Initial DBPCFC outcome was positive in 88 (46%) and
negative in 103 (54%) included challenges. Reactions
ranged from Sampson grade 1 to grade 4, only one child
showed significant changes in vital signs (tachycardia).
Baseline characteristics of children who underwent DBPCFC
are shown in Table 2. Agreement of observers with initial
challenge outcome ranged from 79% - 87%. Based on the
reassessment of score sheets the observers fully agreed on
132 of 191 (69%) DBPCFCs, whether the challenge outcome
was positive or negative. In 47 (25%) challenges one observer
disagreed with the other two, in 12 (6%) challenges complete
disagreement (negative, positive and inconclusive classifica-
tion) was present. Inconclusive challenge outcome was re-
corded by different observers in 58 (10%) reassessments.
Table 2 Baseline characteristics of children who
underwent DBPCFC, n =191
Characteristic
Age, mean (range) in yrs 7.8 (3.4-18.6)
Male sex, n (%) 132 (70)
Peanut sIgE, median (IQR) in kU/L 2.60 (0.60-18.80)
Previous reaction to peanut, n (%)
No ingestion / no reaction 96 (50)
Non severe 63 (33)
Severe 32 (17)
DBPCFC outcome, n (%)*
Negative 103 (54)
Grade 1 2 (1)
Grade 2 51 (27)
Grade 3 15 (8)
Grade 4 20 (11)
*According to the Sampson classification of anaphylaxis [6].
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information (50%), nonspecific symptoms (47%) or unknown
(3%). Overall 111 (58%) score sheets could be used to assess
inter-observer agreement on individual symptoms. On the
remaining 80 (42%) food challenge score sheets no symp-
toms were reported.
Results of inter- and intra-observer analysis are shown
in Table 3. The inter-observer agreement on overall food
challenge outcome was moderate with κ = 0.59-0.65. Ana-
lysis of agreement in challenges with symptoms (n = 111)
showed only fair agreement between observers, κ = 0.31-
0.46. To assess intra-observer variability 48 (25%) ran-
domly selected duplicated score sheets including 27 (14%)
score sheets with reported symptoms could be used. The
intra-observer agreement on overall challenge outcomes
in duplicated challenges was, based on the kappa value,
relatively good (κ = 0.63-0.77). The agreement withinTable 3 Agreement and variability in classification of DBPCFC
All DBPCFC (n =191)
1 2
Agreement with initial DBPCFC outcome 79% 82%
1:2 1:3
Inter-observer agreement 78% 76%
κ (95% CI) 0.65 (0.56-0.74) 0.59 (0.50-0.6
Overall agreement 69%
1 2
Intra-observer agreement* 77% 83%
κ (95% CI) 0.63 (0.45-0.82) 0.71 (0.54-0.8
DBPCFC, Double Blind Placebo Controlled Food Challenge.
κ, Kappa.
*n =48 (All DBPCFC) and n =27 (DBPCFC with symptoms).
Bold numbers express different observers. For example; 1 = observer 1 and 1:2 = oobservers in challenges with symptoms (n = 27) was
however moderate, κ = 0.37-0.60.
Clear objective symptoms (nasal and severe respiratory
symptoms and urticaria) were associated with agreement
whereas mild objective symptoms (mild respiratory symp-
toms, eye symptoms, sneezing and skin symptoms other
than urticaria) and subjective signs and symptoms (OAS,
abdominal complaints and food aversion) were associated
with disagreement between observers (Table 4). The more
different objective symptoms were present the more
agreement between observers was observed (Table 4). The
occurrence of subjective symptoms (e.g. abdominal com-
plaints and OAS) was associated with disagreement within
observers whereas disagreement was never present when
respiratory symptoms occurred (data not shown). Four
children (2%) experienced symptoms on a placebo portion
during challenge, observers disagreed on challenge out-
come in two of these children. Exclusion of children with
placebo reactions did however not change the results of
our study (data not shown).
Discussion
Our results indicate that when presented with the same
clinical information about symptoms during food chal-
lenges, clinical experts often (in more than 30%) disagree
on food challenge outcome. While this fair amount of
disagreement could be seen as disappointing, results
could have been expected. It is known from previous
studies in other disciplines that variability in interpret-
ation of clinical symptoms is often present, despite the
use of guidelines or scoring systems. Investigators of the
Paediatric Rome II criteria for diagnosing functional
gastrointestinal disorders in children showed low inter
observer agreement among gastroenterologists (45% agree-
ment, κ = 0.4), even when using a standardized symptom
scoring system [7]. A study on the agreement between
nurses who triaged patients presenting in the emergencyoutcome
DBPCFC with symptoms (n =111)
3 1 2 3
87% 65% 69% 78%
2:3 1:2 1:3 2:3
76% 76% 61% 60%
8) 0.59 (0.50-0.68) 0.46 (0.39-0.53) 0.35 (0.22-0.48) 0.31 (0.25-0.38)
50%
3 1 2 3
88% 67% 70% 81%
9) 0.77 (0.62-0.92) 0.50 (0.37-0.63) 0.52 (0.39-0.65) 0.60 (0.45-0.60)
bserver 1 versus observer 2.
Table 4 Univariate association of symptoms during challenge with observer agreement, n =191
Tract Symptoms Disagree (n =59) Agree (n =132) p
Upper airways Red/itchy eyes 10 (17) 13 (10) 0.168
Sneezing 10 (17) 10 (8) 0.056
Nasal congestion/rhinorrhoea - 10 (8) 0.043*
Lower airways Cough 5 (9) 6 (5) 0.282
Hoarseness/difficulty swallowing - 3 (2) 0.243
In- and/or expiratory stridor - 5 (4) 0.130
Wheezing - 4 (3) 0.177
Dyspnoea 3 (5) 2 (2) 0.153
Gastro-intestinal OAS^ 28 (48) 12 (9) 0.000**
Abdominal complaints^ 21 (36) 6 (5) 0.000**
Vomiting 4 (7) 5 (4) 0.374
Diarrhoea - - -
Skin Contact urticaria# 9 (15) 13 (9) 0.283
Redness 12 (20) 9 (7) 0.008**
Pruritis 4 (7) 6 (5) 0.525
Urticaria - 10 (8) 0.043*
Angioedema - 2 (2) 0.342
Neurological Change in activity level/loss of consciousness - - -
Other subjective signs Discomfort^ 2 (3) 10 (8) 0.283
Food aversion^ 14 (24) 10 (8) 0.003**
Number of different objective symptoms No objective symptoms 18 (32) 2 (4) Ref
1 symptom 22 (39) 23 (40) 0.005**
2 symptoms 13 (23) 22 (40) 0.001**
3 symptoms 3 (5) 8 (15) 0.002**
OAS, Oral Allergy Symptoms; Ref, Reference category.
^Symptoms referred to as subjective symptoms.
#Local urticaria after direct contact between the challenge material and skin.
*Statistical significant association with agreement.
**Statistical significant association with disagreement.
Bold numbers are statistically significant (p <0.05).
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a low level of agreement (κ = 0.3) among pediatric asthma
specialists in classifying asthma serverity according to the
NIH guidelines was found previously [9].
The origin of disagreement between and within ob-
servers observed in this study can be explained in several
ways. Our results indicate that not the number but the
origin and severity of symptoms is related to the amount
of disagreement between observers. This is in contrast
to previous suggestions that there is less room for doubt
about challenge outcome when two or more organ sys-
tems are involved or when symptoms are reproducible
or persisting [10]. Due to the amount of variability in
course of symptoms during challenge between patients,
we were unfortunately not able to demonstrate whether
the timing of symptoms was related to the level of agree-
ment between observers.Subjective symptoms or mild objective symptoms (one
episode of vomiting or a transient rash) frequently occur
in children, usually as the first sign of an allergic reac-
tion during food challenges. However these symptoms
can also indicate fear associated with the clinical setting
of the challenge or intolerance for the amount of food
or the matrix chosen. As mainly subjective symptoms
were present in cases on which observers disagreed one
could argue that observers have difficulties in the inter-
pretation of food challenge outcome when clear objective
symptoms are absent. Moreover, guidelines only provide
information on symptoms likely to be associated with
positive challenge outcome and can therefore be inter-
preted and implemented by each observer differently. Reli-
ability of the assessment of food challenges outcome also
depends on the information provided. In our study lack of
knowledge of the guidelines is unlikely to influence the
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food allergy and used to perform and interpret food chal-
lenges. The same clinical information was administered to
all observers excluding the possibility of sampling error.
Assessment of challenge outcome was based on paper
score sheets eliminating the possibility that the interpret-
ation of observers and results of this study were influenced
by other (patient related) factors as level of sensitization,
age or previous challenge results.
To our knowledge this is the first study exploring
agreement between clinical experts in assessing food
challenge outcome. Observers reassessed a large number
of challenges in a blinded, standardized and accurate
way. Due to the retrospective nature there are some lim-
itations that should be considered when interpreting the
results of this study. Placebo reactions can influence chal-
lenge outcome in young children [11]. DBPCFCs were
performed with randomly interspersed placebo’s, but
observers had only access to blinded score sheets. Unfor-
tunately we were therefore not able to analyse differences
between placebo or verum challenges. Challenges were
reassessed after two years, based on recorded symptoms
during challenge, no additional (photographic or real life)
patient information was available. The food challenges
score sheet was not validated and lack of information
could have caused differences between observers. Based
on our results we can therefore not conclude that ob-
servers would classify challenge outcome of actual patients
in the same manner as they did based on paper score
sheets. However it is possible that the lack of agreement
we found is even an underestimation of variability in
assessment of ‘real life’ challenges since conditions in this
study were standardized in contrast to real life reactions
where observers are influenced by many other (patient
related) factors.
Conclusion
Although our study using symptom score sheets might
not fully reflect procedures in a real life setting, our ob-
servations indicate that different observers may have dif-
ferent opinions about symptoms during food challenge
tests. To further investigate whether this variability is also
present during real life challenges future prospective stud-
ies using an expert panel or for example a scoring system
with weightage points for each (type of) symptom to
assess food challenge outcomes are needed. To improve
standardization of food challenges and diminish variability
in interpretation new preferably objective parameters
might also be helpful in the future [12-16]. Until now,
clinicians should be aware that although experienced
and familiar in working according to international guide-
lines variability in interpretation of food challenge outcome
is present when reassessing score sheets of challenges,
especially when objective symptoms are absent.Abbreviations
DBPCFC: Double blind placebo controlled food challenge; OAS: Oral allergy
symptoms.
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